Investors & Media
Our science-driven strategy allows us to advance our programs with sound execution and ultimately bring long-term value to patients. Follow the journey of our dedicated scientists and drug developers or learn how you can contribute to our mission.
Our science-driven strategy allows us to advance our programs with sound execution and ultimately bring long-term value to patients. Follow the journey of our dedicated scientists and drug developers or learn how you can contribute to our mission.
Investor Opportunities
Contact UsLatest News
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
September 20, 2023
1STBIO 신규 사명 / CI 공모전 결과 공고
August 18, 2023
신주 발행 공고
June 29, 2023
합병종료보고 공고
June 2, 2023
신주 발행 공고
June 2, 2023
신주 발행 공고
May 2, 2023
채권자 이의제출 및 주권제출 공고
April 19, 2023
소규모 합병 공고
April 3, 2023
제7기 정기주주총회 소집공고(정정)
March 29, 2023
소규모 합병을 위한 기준일 공고
March 16, 2023
